414
Participants
Start Date
February 29, 2000
Primary Completion Date
February 28, 2011
Study Completion Date
May 31, 2011
Percutaneous closure of patent foramen ovale
Percutaneous implantation of an AMPLATZER® PFO Occluder
Medical antitrhombotic treatment
Investigator's choice: Anticoagulation to INR 2.0 - 3.0 OR Aspirin 100-325 mg/d OR Clopidogrel 75-150 mg/d
Universitätsklinik für Innere Medizin II, Vienna
A.Z. Sint-Jan AV, Bruges
Monash Medical Centre, Melbourne
Sir Charles Gairdner Hospital, Nedlands
Alfred Hospital, Prahan
University Hospital / Inselspital, Bern
Collaborators (1)
Abbott Medical Devices
INDUSTRY
Foundation for Cardiovascular Research, Zurich
OTHER